Virtual home: personalized therapy of patients in palliative oncology using virtual reality

Not Applicable

• Conditions: C00-C97; Malignant neoplasms

• Registration Number: DRKS00032172
• Lead Sponsor: niversitätsklinikum Heidelberg, Klinik für Palliativmedizin

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2023-07-11
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 10

Inclusion Criteria

Inclusion criteria for patient:s:
- Diagnosis of oncologic or hematologic disease that is not curable or has an uncertain prognosis.
- Capacity to give consent

Inclusion criteria for relatives:
- relatives of a patient with a diagnosis of an oncologic or hematologic disease that is not curable or is associated with an uncertain prognosis
- Capacity to consent

Inclusion criteria for members of the patient advisory board, or patient representatives and health care professionals:
- Counseling and care of patients with an oncologic or hematologic disease that is not curable or is associated with an uncertain prognosis.
- Capacity to consent

Exclusion Criteria

Exclusion criteria for patients:
- Patients who, in the opinion of the treating team, are in a too poor general condition or too stressed to participate in a study of any kind.
- Cognitive or communicative deficits
- visual disturbances
- Injuries in the area of the head, which are associated with possible risks for the patients when using the VR goggles.
- Life expectancy of a few days

Exclusion criteria for relatives:
- Relatives who feel too burdened to participate in a study of any kind
- Cognitive or communication deficits
- Relatives of dying patients

Exclusion criteria for members of the patient advisory board, or patient representative:s, and health care professionals:
- Cognitive or communication deficits

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
(1) Symptom perception, well-being and treatment experience using validated questionnaires, treatment adherence, pain medication, vegetative functionality.<br>(2) Feedback and suggestions for improvement from patients, relatives and patient advisory council based on the results of (1).